Int J Gastrointest Interv 2022; 11(3): 132-134
Published online July 31, 2022 https://doi.org/10.18528/ijgii210049
Copyright © International Journal of Gastrointestinal Intervention.
Sachin Yadav1,* , Praveen Kumar Sharma1, Sudhir Kumar Singh1 , Atul Abhishek Jha1 , Reethesh1 , and Anurag Garg2
1Department of Gastroenterology, Army Hospital Research and Referral, Delhi Cantt, India
2Department of Anaesthesiology, Army Hospital Research and Referral, Delhi Cantt, India
Correspondence to:*Department of Gastroenterology, Army Hospital Research and Referral, Delhi Cantt 110010, India.
E-mail address: firstname.lastname@example.org (S. Yadav).
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the modern era, endoscopic retrograde cholangiopancreatography (ERCP) and therapeutic endoscopic ultrasound (EUS) are increasingly being performed in day-care settings. The safety of these procedures in elderly admitted patients has been established in previous studies, but evidence for the safety of day-care ERCP/therapeutic EUS is limited. We retrospectively analyzed the outcomes of day-care ERCP/EUS in patients more than 80 years of age. All procedures were done under total intravenous anesthesia (ketamine- and propofol-based) and the intra-procedural and immediate postprocedural complications (within 6 hours) were noted. Thirty patients (24 male and 6 female) were enrolled. The most common indication for the procedure was choledocholithiasis (46.6%), followed by malignant stenosis (30.0%) and benign strictures (20.0%). One patient had transient desaturation during the procedure and two patients had hypotension. The dreaded complications of bleeding, perforation, or pancreatitis did not occur in any patients, and none required admission. In conclusion, day-care therapeutic ERCP/EUS is safe and cost-effective in the oldest old patients.
Keywords: Cholangiopancreatography, endoscopic retrograde, Daycare, Oldest old, Safety, Therapeutic endoscopic ultrasound
With improving access to healthcare, there has been a global increase in the average age. It is predicted that by 2050, 2 billion people will be above the age of 60 years and 434 million above 80 years, as compared to 900 million and 125 million, respectively, in 2015, and that 80% will live in low- and middle-income countries.1 The elderly population has been sub-classified as the oldest old (> 80 years), centenarians (100+), and super-centenarians (110+).2 Two points are important to note. Firstly, the elderly population has a higher prevalence of comorbidities requiring medication and may prefer outpatient procedures in view of their poor ambulation and dependency on family and social support. Secondly, there is a high incidence of disorders in octogenarians warranting endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS).3 ERCP is complicated by pancreatitis, perforations, gastrointestinal bleeding, and cholangitis. Although the currently available literature shows that ERCP is safe in the elderly population, the presence of concomitant frailty, multiple co-morbidities, and poor cognition has led endoscopists to consider avoiding interventions unless the indication is life-saving.4 Furthermore, while studies have established the safety of ERCP/EUS on an outpatient basis,5,6 data are lacking on outpatient therapeutic ERCP/EUS in patients aged 80 years and older from India. The current retrospective study was done to establish the safety of outpatient therapeutic ERCP/EUS in patients aged 80 years or older.
The existing medical records for all ERCP/EUS procedures were screened for patients aged more than 80 years who had undergone ERCP/EUS on a day-care basis (observed for 6 hours in the endoscopy recovery room to monitor them for any complications and discharged on the same day). As per the protocol in our hospital, a careful pre-anesthetic check-up (PAC) was carried out for all patients, and were given an appropriate American Society of Anesthesiologists (ASA) classification. During procedure, all patients were pre-medicated with fentanyl (1 μg/kg and titrated further according to the effect, with a maximum of 2 μg/kg) and ondansetron (4 mg), intravenously. All patients were given total intravenous anesthesia (intravenous propofol at 5 μg/kg and intravenous ketamine at 1 mg/kg, titrated to effect) and were monitored for any anesthesia-related complications during and after the procedure.
Pancreatitis was defined as new-onset abdominal pain with at least a three-fold elevation of serum amylase or lipase levels that required more than 1 night of hospitalization. Perforation was defined as retroperitoneal or bowel-wall perforation, as evidenced by any imaging technique. Bleeding adverse events were defined as clinically evident hemorrhage, with a decrease in hemoglobin of at least 2 g/dL or the need for endo-therapy or transfusion. Cholangitis was defined as a temperature of more than 38°C for 24–48 hours occurring after the procedure that was thought to have a biliary cause, without evidence of other concomitant infections. Cardio-pulmonary adverse events included myocardial infarction, cerebrovascular accident, congestive heart failure, cardiac/respiratory arrest, arrhythmia including bradycardia (heart rate < 60 beats/minute), tachycardia (heart rate > 110 beats/minute), or vasovagal response. Hypoxemia was defined as oxygen saturation < 90% by pulse oximetry and hypotension was defined as a systolic blood pressure < 90 mmHg.
Patients were advised to report back in case of fever, abdominal pain, vomiting, or any other complication. After discharge, we followed our patients telephonically on a daily basis for 7 days and reviewed them at the outpatient department after 7 days to evaluate the efficacy of the procedure or to address any complications.
We collected retrospective data on patients undergoing EUS/ERCP from endoscopy records from January 2019 through December 2019 at Department of Gastroenterology at Army Hospital (Referral and Research) and screened patients who were above 80 years. A total of 534 patients underwent ERCP/EUS in the study period, of whom 48 were more than 80 years of age.
Thirty patients underwent day-care procedures and were enrolled in the study. During the PAC, 70.0% (
The mean age of the patients was 86.7 years. The majority of patients were male (
Table 1 . Characteristics of the Oldest Old Undergoing Day-Care ERCP/EUS.
|80–89 yr||25 (83.3)|
|90–99 yr||4 (13.3)|
|100 yr and above||1 (3.3)|
|Benign biliary strictures||6 (20.0)|
|Malignant stenosis||9 (30.0)|
|Pancreatic pseudocyst||1 (3.3)|
|Coronary artery disease||1 (3.3)|
|Complete heart block||2 (6.6)|
|Rheumatoid arthritis||2 (6.6)|
|No comorbidities||8 (26.6)|
|Stent placement||26 (86.6)|
|EUS-guided cysto-gastrostomy||1 (3.3)|
|EUS-guided rendezvous ERCP||1 (3.3)|
|EUS-guided choledochoduodenostomy||1 (3.3)|
|Incomplete procedure||1 (3.3)|
|Cardiopulmonary complications||1 (3.3)|
ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound..
During ERCP, 76.6% (
Therapeutic EUS was performed in 10.0% (
Transient complications such as desaturation during the procedure (6.6%,
ERCP is the procedure of choice for the treatment of choledocholithiasis and is used frequently as a drainage procedure for extrahepatic biliary obstruction, both of which have a higher incidence in the elderly population. ERCP is technically demanding compared to colonoscopy and esophago-gastroduodenoscopy and is associated with complications such as pancreatitis, bleeding, and perforation, in addition to anesthesia-related complications.7 Therefore, the safety and success of ERCP and EUS in elderly patients should be assessed and ensured.
Outpatient ERCP is now gaining acceptance worldwide, and its safety has been established in various studies.8 As elderly patients have a high prevalence of associated comorbid conditions (mainly cardiopulmonary), which predispose them to increased procedural and anesthesia-related adverse effects, most centers prefer to perform these procedures on an inpatient basis. Hui et al5 reported that 85% of all complications developed within 6 hours after the procedure. The authors also found that all cases of post-ERCP pancreatitis or nonspecific abdominal pain occurred within 6 hours. Similarly, Freeman et al9 concluded that 79% of complications were reported within 6 hours after ERCP. However, in studies where patients were observed for 1 to 4 hours, 4% of the outpatients subsequently developed post-ERCP pancreatitis, requiring readmission to the hospital.6,10 These results indicate that while complications may be more common in the elderly, they, like complications in younger patients, tend to manifest within the first 6 hours. The fact that our outpatient ERCP protocol involved a minimum observation period of 6 hours mitigates this risk and indicates that the procedure could be safe. This study presents our experiences of ERCP/EUS as a day-care procedure in the elderly.
In our patients, delayed post-endoscopic sphincterotomy bleeding, pancreatitis, perforation, and cholangitis were not observed in any patients. Jeurnink et al11 observed that cholangitis and hemorrhage requiring re-admission each occurred in 1% of patients who underwent ERCP as outpatient treatment.
The oldest old patients have higher chances of sedation-related adverse effects. Finkelmeier et al12 reported that adverse events related to sedation occurred significantly more commonly in elderly patients (> 80 years) than in younger patients (3.4% vs. 0.5%;
In the present era with rising healthcare costs, the feasibility of performing ERCP/EUS safely in the day-care/outpatient setting has become of paramount importance. Avenues to reduce high costs rely on more efficient medical care. Because of the expected risk of complications in the elderly, overnight observation after ERCP is common. This policy, albeit useful, causes unnecessarily high health costs and inefficient use of medical resources. A possible solution is shifting from inpatient to outpatient treatments and to reserve admission only for patients with complications or with a high risk of complications; however, careful selection of patients eligible for ERCP on an outpatient basis is required. Patients with relatively good health status who are not at risk for post-ERCP complications may be considered for outpatient or day-care procedures if they have normal coagulation tests and metabolic profile and are staying near the hospital.
The strengths of this case series are consecutive patient selection from a single tertiary care center and close follow-up of patients during the observational period by the endoscopy and anesthesia team with more than 15 years of experience in ERCP. Its limitations include the retrospective nature of data collection.
In conclusion, this study demonstrated that therapeutic outpatient ERCP/EUS can be done by experienced endoscopy and anesthetic teams even in the oldest old patients with associated comorbid diseases, and are acceptable and safe, avoiding unnecessary hospital admissions.
No potential conflict of interest relevant to this article was reported.
© The Society of Gastrointestinal Intervention. Powered by INFOrang Co., Ltd.